title: Key Issues Related to Cryopreservation and Storage of Stem Cells and Cancer Stem Cells: Protecting Biological Integrity.
abstract: Cryopreservation and biobanking of stem cells are becoming increasingly important as stem cell technology and application attract the interest of industry, academic research, healthcare and patient organisations. Stem cell are already being used in the treatment of some diseases and it is anticipated that stem cell therapy will play a central role in future medicine. Similarly, the discovery of both hematopoietic and solid tumor stem cells and their clinical relevance have profoundly altered paradigms for cancer research as the cancer stem cells are considered promising new targets against cancer. Consequently, long-term cryopreservation and banking of normal and malignant stem cells is crucial and will inevitably become a routine procedure that requires highly regulated and safe methods of specimen storage. There is, however, an increasing amount of evidence showing contradictory results on the impact of cryopreservation and thawing of stem cells, including extensive physical and biological stresses, apoptosis and necrosis, mitochondrial injuries, changes to basal respiration and ATP production, cellular structural damage, telomere shortening and cellular senescence, and DNA damage and oxidative stress. Notably, cell surface proteins that play a major role in stem cell fate and are used as the biomarkers of stem cells are more vulnerable to cold stress than other proteins. There are also data supporting the alteration in some biological features and genetic integrity at the molecular level of the post-thawed stem cells. This article reviews the current and future challenges of cryopreservation of stem cells and stresses the need for further rigorous research on the methodologies for freezing and utilizing cancer stem cells following long-term storage.
authors.affiliation: Department of Oncology, University of Alberta, Edmonton, AB, Canada. fkarimi@ualberta.ca.
authors.forename: Feridoun
authors.initials: F
authors.lastname: Karimi-Busheri
authors.affiliation: Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton, AB, Canada.
authors.forename: Aghdass
authors.initials: A
authors.lastname: Rasouli-Nia
authors.affiliation: Department of Oncology, Cross Cancer Institute and University of Alberta, Edmonton, AB, Canada. Michael.Weinfeld@albertahealthservices.ca.
authors.forename: Michael
authors.initials: M
authors.lastname: Weinfeld
mesh_terms: D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D018070:Biological Specimen Banks; D015415:Biomarkers / Q000378:metabolism; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000494:pharmacology*; D015870:Gene Expression; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018396:Mucin-1 / Q000235:genetics / Q000378:metabolism; D014411:Neoplastic Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D058989:Vitrification
chemical_list: D015703:Antigens, CD; D015415:Biomarkers; D003451:Cryoprotective Agents; C060192:MUC1 protein, human; D018396:Mucin-1
keywords: Cancer stem cells; Cell surface proteins; Cryopreservation; Embryonic stem cells; Lungospheres; Mammospheres; Membrane proteins; Mesenchymal stem cells; Proliferation; Vitrification